The results of these analyses clearly support the argument that oxybutynin XL provides a cost-effective therapeutic option compared with tolterodine IR. In fact, oxybutynin XL dominates ...

There are many new treatment options for the overactive bladder that are discussed in this article, including the recently introduced drugs tolterodine and oxybutynin XL. Other drugs are in ...

When taken with anticholinergic drugs, bacopa can cause an even greater reduction. Anticholinergics—like Ditropan XL (oxybutynin) for overactive bladder (OAB)—might worsen this problem and work ...

A frequent reason for discontinuation of therapy is dry mouth, which is reported by as many as 80% of patients receiving the immediate-release formulation of oxybutynin (widely considered the ...